EVH Evolent Health, Inc.
Healthcare$3.83-3.04%ClosedMarket Cap: $430.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.12
P/S
0.24
EV/EBITDA
12.33
DCF Value
$-18.35
FCF Yield
0.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
14.1%
Operating Margin
-0.9%
Net Margin
-26.3%
ROE
-77.9%
ROA
-26.4%
ROIC
-1.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $496.2M | 12.5% | $-10.1M | $-26.6M | $— | — |
| Q4 null | $468.7M | 11.1% | $-9.6M | $-429.1M | $— | — |
| FY null | $1.88B | 15.1% | $-4.4M | $-534.5M | $— | — |
| Q3 null | $479.5M | 15.8% | $658.0K | $-20.9M | $— | — |
| Q2 null | $444.3M | 17.3% | $2.8M | $-19.9M | $— | — |
| Q1 null | $483.6M | 21.2% | $-1.6M | $-64.6M | $— | — |
| Q4 null | $646.5M | 11.7% | $-18.6M | $-22.8M | $— | — |
| FY null | $2.55B | 14.4% | $-40.5M | $-61.6M | $— | — |
| Q3 null | $621.4M | 13.0% | $-16.3M | $-23.1M | $— | — |
| Q2 null | $647.1M | 16.5% | $7.8M | $1.6M | $— | — |
| Q1 null | $639.7M | 16.3% | $-13.4M | $-17.3M | $— | — |
| Q4 2023 | $556.1M | 18.3% | $-21.4M | $-33.4M | $-0.36 | — |